Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Pemafibrate by Kowa for Primary Biliary Cholangitis (Primary Biliary Cirrhosis): Likelihood of Approval
Pemafibrate is under clinical development by Kowa and currently in Phase II for Primary Biliary Cholangitis (Primary Biliary Cirrhosis). According...
Ripasudil hydrochloride hydrate by Kowa for Corneal Edema: Likelihood of Approval
Ripasudil hydrochloride hydrate is under clinical development by Kowa and currently in Phase III for Corneal Edema. According to GlobalData,...
Ripasudil hydrochloride hydrate by Kowa for Fuchs Endothelial Corneal Dystrophy (FECD): Likelihood of Approval
Ripasudil hydrochloride hydrate is under clinical development by Kowa and currently in Phase III for Fuchs Endothelial Corneal Dystrophy (FECD)....
K-161 by Kowa for Keratoconjunctivitis Sicca (Dry Eye): Likelihood of Approval
K-161 is under clinical development by Kowa and currently in Phase III for Keratoconjunctivitis Sicca (Dry Eye). According to GlobalData,...